US 11760803
Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
granted A61KA61K2039/507A61P
Quick answer
US patent 11760803 (Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments) held by Takeda Pharmaceutical Company Limited expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/507, A61P, A61P35/00, A61P37/06